The company said, “Kestra expects revenue for fiscal year ending April 30, 2025 to be in the range of $58.0 million to $58.5 million, representing growth of approximately 109% to 110% compared to fiscal year 2024.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMTS:
- Kestra Medical Technologies Ltd.: Positioned for Growth with Strong Financials and Innovative Market Strategy
- Kestra Medical Technologies: Strong Growth Potential Balanced by Current Valuation in MedTech Sector
- Kestra Medical initiated with a Buy at BofA
- Kestra Medical Technologies: Positioned for Growth in the Wearable Cardioverter Defibrillator Market
- Kestra Medical initiated with an Outperform at Wolfe Research